Know Cancer

or
forgot password

Radiation Oncology Quality of Life and Tissue Banking Protocol


N/A
N/A
89 Years
Open (Enrolling)
Both
Patients With Pathologically Confirmed Neoplasia That Have Been, Selected for Definitive Photodynamic Therapy, Proton, or Photon, Radiotherapy.

Thank you

Trial Information

Radiation Oncology Quality of Life and Tissue Banking Protocol


Inclusion Criteria:



- Donors will be between the ages of 18 and 89 with pathologically confirmed neoplasia
that are selected for definitive photodynamic therapy, proton, photon radiotherapy

- Pediatric patients with pathologically confirmed neoplasia that have been selected
for definitive radiotherapy may elect to participate in a pediatric arm of quality of
life, provided that the proper processes of parental permission and assent have
occurred.

- Patients between the ages of 18 and 89 receiving palliative proton or photon
radiotherapy will be eligible to permit the collection of their clinical and
technical data for the purpose of the IGRT Registry component of this protocol.

Exclusion Criteria:

- Patient under the age of 18 will not be eligible to participate in the tissue banking
component of this study.

- Patient presenting for palliative proton or photon radiotherapy will be excluded from
the QOL and Tissue Banking components of this study.

- Patients over the age of 89 will excluded from all arms of this study.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Health Assessments

Safety Issue:

No

Principal Investigator

Ramesh Rengan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Abramson Cancer Center of the University of Pennsylvania

Authority:

United States: Institutional Review Board

Study ID:

UPCC 11908

NCT ID:

NCT01577251

Start Date:

June 2008

Completion Date:

Related Keywords:

  • Patients With Pathologically Confirmed Neoplasia That Have Been
  • Selected for Definitive Photodynamic Therapy, Proton, or Photon
  • Radiotherapy.
  • Neoplasms

Name

Location

Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, Pennsylvania  19104-4283